West Tower Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-114	Closed	-$15K	–	367
2023 Q4	$15K	Buy	+114	New	+$15K	0.03%	315